申请人:CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD.
公开号:US20170240519A1
公开(公告)日:2017-08-24
Provided is a benzofuran analogue having a structure represented by formula (I) and used as an NS4B inhibitor, or a pharmaceutically acceptable salt of the benzofuran analogue. The benzofuran analogue has anti-hepatitis C virus activity.